423 related articles for article (PubMed ID: 6649025)
1. Characterization of biochemical changes occurring during storage of red cells. Comparative studies with CPD and CPDA-1 anticoagulant-preservative solutions.
Moroff G; Dende D
Transfusion; 1983; 23(6):484-9. PubMed ID: 6649025
[TBL] [Abstract][Full Text] [Related]
2. Survival and biochemical characteristics of stored red cells preserved with citrate-phosphate-dextrose-adenine-one and two and prepared from whole blood maintained at 20 to 24 degrees C for eight hours following phlebotomy.
Moroff G; Morse EE; Katz AJ; Kahn RA; Dende D; Swatman L; Staggs SD
Transfusion; 1984; 24(2):115-9. PubMed ID: 6710583
[TBL] [Abstract][Full Text] [Related]
3. In vivo viability of red blood cells stored in CPDA-2.
Sohmer PR; Moore GL; Beutler E; Peck CC
Transfusion; 1982; 22(6):479-84. PubMed ID: 7147326
[TBL] [Abstract][Full Text] [Related]
4. Effects of irradiation on red cells stored in CPDA-1 and CPD-ADSOL (AS-1).
Jeter EK; Gadsden RH; Cate J
Ann Clin Lab Sci; 1991; 21(3):177-86. PubMed ID: 1905899
[TBL] [Abstract][Full Text] [Related]
5. The biochemical effects of CPDA-2-drawn red blood cells of delayed refrigeration prior to component preparation.
Moore GL; Ledford ME; Merydith A
Transfusion; 1982; 22(6):485-7. PubMed ID: 7147327
[TBL] [Abstract][Full Text] [Related]
6. Red cell storage for 56 days in modified DPD-adenine. An in vitro evaluation.
Moore GL; Ledford ME; Unruh KA; Brummell MR
Transfusion; 1981; 21(6):699-701. PubMed ID: 7314217
[TBL] [Abstract][Full Text] [Related]
7. Dihydroxyacetone, pyruvate, and phosphate effects on 2,3 DPG and ATP in citrate-phosphate-dextrose-adenine blood preservation.
Dawson RB; Fagan DS; Meyer DR
Transfusion; 1984; 24(4):327-9. PubMed ID: 6464157
[TBL] [Abstract][Full Text] [Related]
8. Modified formulation of CPDA for storage of whole blood, and of SAGM for storage of red blood cells, to maintain the concentration of 2,3-diphosphoglycerate.
Kurup PA; Arun P; Gayathri NS; Dhanya CR; Indu AR
Vox Sang; 2003 Nov; 85(4):253-61. PubMed ID: 14633250
[TBL] [Abstract][Full Text] [Related]
9. Viability and function of red blood cell concentrates stored at 4 degrees C for 35 days in CPDA-1, CPDA-2, or CPDA-3.
Valeri CR; Valeri DA; Gray A; Melaragno A; Dennis RC; Emerson CP
Transfusion; 1982; 22(3):210-6. PubMed ID: 7090034
[No Abstract] [Full Text] [Related]
10. The in vitro evaluation of modifications in CPD-adenine anticoagulated-preserved blood at various hematocrits.
Moore GL; Ledford ME; Peck CC
Transfusion; 1980; 20(4):419-26. PubMed ID: 7404640
[TBL] [Abstract][Full Text] [Related]
11. Storage of red cell concentrates in CPD-A2 for 42 and 49 days.
Beutler E; West C
J Lab Clin Med; 1983 Jul; 102(1):53-62. PubMed ID: 6854134
[TBL] [Abstract][Full Text] [Related]
12. Red cell ATP and 2,3-diphosphoglycerate concentrations as a function of dihydroxyacetone supplementation of CPD adenine.
Moore GL; Ledford ME; Brummell MR
Vox Sang; 1981; 41(1):11-7. PubMed ID: 7324438
[TBL] [Abstract][Full Text] [Related]
13. Red blood cell aging markers during storage in citrate-phosphate-dextrose-saline-adenine-glucose-mannitol.
Antonelou MH; Kriebardis AG; Stamoulis KE; Economou-Petersen E; Margaritis LH; Papassideri IS
Transfusion; 2010 Feb; 50(2):376-89. PubMed ID: 19874562
[TBL] [Abstract][Full Text] [Related]
14. The 24-hour posttransfusion survival, oxygen transport function, and residual hemolysis of human outdated-rejuvenated red cell concentrates after washing and storage at 4 degrees C for 24 to 72 hours.
Valeri CR; Gray AD; Cassidy GP; Riordan W; Pivacek LE
Transfusion; 1984; 24(4):323-6. PubMed ID: 6464156
[TBL] [Abstract][Full Text] [Related]
15. Manufacture of red cells in additive solution from whole blood refrigerated for 5 days or remanufactured from red cells stored in plasma.
Wiltshire M; Cardigan R; Thomas S
Transfus Med; 2010 Dec; 20(6):383-91. PubMed ID: 20681977
[TBL] [Abstract][Full Text] [Related]
16. Storage of saline-adenine-glucose-mannitol-suspended red cells in a new plastic container: polyvinylchloride plasticized with butyryl-n-trihexyl-citrate.
Högman CF; Eriksson L; Ericson A; Reppucci AJ
Transfusion; 1991 Jan; 31(1):26-9. PubMed ID: 1898784
[TBL] [Abstract][Full Text] [Related]
17. Xanthone additives for blood storage that maintain its potential for oxygen delivery. I. 2-Hydroxyethoxy- and 2-ethoxy-6-(5-tetrazoyl) xanthones in citrate-phosphate-dextrose-adenine (CPDA-1) blood.
Paterson RA; Dawson J; Hyde RM; Livingstone DJ; Parry ES; Nash S; Boyce IM
Transfusion; 1988; 28(1):34-7. PubMed ID: 3341063
[TBL] [Abstract][Full Text] [Related]
18. Half-strength citrate CPD combined with a new additive solution for improved storage of red blood cells suitable for clinical use.
Högman CF; Eriksson L; Gong J; Högman AB; Vikholm K; Debrauwere J; Payrat JM; Stewart M
Vox Sang; 1993; 65(4):271-8. PubMed ID: 8310679
[TBL] [Abstract][Full Text] [Related]
19. Impact of the anticoagulant-preservative citrate-phosphate-adenine (CPDA-1) on blood services.
McEvoy PM; Kahn RA; Miller WV
Transfusion; 1982; 22(6):532-4. PubMed ID: 7147334
[TBL] [Abstract][Full Text] [Related]
20. Adequate survival of red cells from units "undercollected" in citrate-phosphate-dextrose-adenine-one.
Davey RJ; Lenes BL; Casper AJ; Demets DL
Transfusion; 1984; 24(4):319-22. PubMed ID: 6464155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
